Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleGASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

α2-Adrenergic Receptors Stimulate Oligopeptide Transport in a Human Intestinal Cell Line

Françoise Berlioz, Jean-José Maoret, Hervé Paris, Marc Laburthe, Robert Farinotti and Claude Rozé
Journal of Pharmacology and Experimental Therapeutics August 2000, 294 (2) 466-472;
Françoise Berlioz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-José Maoret
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hervé Paris
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Laburthe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Farinotti
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claude Rozé
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Di- and tripeptides, as well as peptidomimetic drugs such as cephalexin (CFX), are absorbed by enterocytes via the oligopeptide transporter PepT1. We recently showed that the α2-adrenergic agonist clonidine increases CFX absorption in anaesthetized rats. Herein, we investigated whether α2-adrenergic receptors can directly affect PepT1 activity in a clone of the differentiated human intestinal cell line Caco-2 (Caco-2 3B) engineered to stably express α2A-adrenergic receptors at a density similar to that found in normal mucosa. Measurement of CFX fluxes across cell monolayers cultured on transwell filters demonstrated that the α2-agonists clonidine and UK14304 caused a 2-fold increase of CFX transport in Caco-2 3B cells, but not in Caco-2 (expressing PepT1 but not α2-adrenergic receptors) or in the HT29 19A clone (expressing α2-adrenergic receptors but not PepT1). The stimulatory effect of clonidine was abolished by glycyl-sarcosine (a competitor for the transporter) and blocked by yohimbine or RX821002 (α2-antagonists). Analysis of the kinetics of CFX transport in control and clonidine-treated Caco-2 3B cells showed that clonidine increased Vmaxof CFX transport without changing Km. Clonidine action was abolished by colchicine but not altered by amiloride, demonstrating that microtubule integrity but not Na+/H+ exchanger activity is necessary for the effect of α2-agonists to occur. In conclusion, clonidine can directly activate α2-adrenergic receptors located on epithelial cells. The precise molecular mechanisms whereby these receptors modulate PepT1 activity remain to be elucidated but an increased translocation to the apical membrane of preformed cytoplasmic transporter molecules is likely to be involved.

Footnotes

  • Send reprint requests to: Dr. C. Rozé, Institut National de la Santé et de la Recherche Médicale U410, Faculté de Médecine X. Bichat, 16 rue H. Huchard, 75018 Paris, France. E-mail: roze{at}bichat.inserm.fr

  • ↵1 This study was funded in part by Institut de Recherches sur les Maladies de l′Appareil Digestif and by Association Charles Debray. F.B. was the recipient of a grant from the Fondation pour la Recherche Médicale.

  • Abbreviations:
    PepT1
    H+/peptide cotransporter
    CFX
    cephalexin
    DMEM
    Dulbecco's modified Eagle's medium
    FCS
    fetal calf serum
    UK14304
    5-bromo-6-(2-imidazoline-2-ylamino)-quinoxaline
    RX821002
    2-(2-methoxy-1,4-benzodioxan-2-yl)-2-imidazoline
    RT-PCR
    reverse transcription-polymerase chain reaction
    TEER
    transepithelial electrical resistance
    • Received February 10, 2000.
    • Accepted April 7, 2000.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 294 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 294, Issue 2
1 Aug 2000
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
α2-Adrenergic Receptors Stimulate Oligopeptide Transport in a Human Intestinal Cell Line
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleGASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

α2-Adrenergic Receptors Stimulate Oligopeptide Transport in a Human Intestinal Cell Line

Françoise Berlioz, Jean-José Maoret, Hervé Paris, Marc Laburthe, Robert Farinotti and Claude Rozé
Journal of Pharmacology and Experimental Therapeutics August 1, 2000, 294 (2) 466-472;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleGASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

α2-Adrenergic Receptors Stimulate Oligopeptide Transport in a Human Intestinal Cell Line

Françoise Berlioz, Jean-José Maoret, Hervé Paris, Marc Laburthe, Robert Farinotti and Claude Rozé
Journal of Pharmacology and Experimental Therapeutics August 1, 2000, 294 (2) 466-472;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Experimental Procedures
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • H2S Overproduction and Colonic Hypomotility in DM
  • A Novel Long-Acting GLP-2, HM15912, for Short Bowel Syndrome
  • MIP3a in Progressive Renal Injury Associated With Obesity
Show more Gastrointestinal, Hepatic, Pulmonary, and Renal

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics